OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Spotlight on Givosiran as a Treatment Option for Adults with Acute Hepatic Porphyria: Design, Development, and Place in Therapy
Chaudry Nasir Majeed, D. Christopher, Ted Xiao, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 1827-1845
Open Access | Times Cited: 25
Chaudry Nasir Majeed, D. Christopher, Ted Xiao, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 1827-1845
Open Access | Times Cited: 25
Showing 25 citing articles:
mRNA in the Context of Protein Replacement Therapy
Theofanis Vavilis, Εleni Stamoula, Alexandra Ainatzoglou, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 166-166
Open Access | Times Cited: 66
Theofanis Vavilis, Εleni Stamoula, Alexandra Ainatzoglou, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 166-166
Open Access | Times Cited: 66
AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review
Bruce Wang, Herbert L. Bonkovsky, Joseph K. Lim, et al.
Gastroenterology (2023) Vol. 164, Iss. 3, pp. 484-491
Open Access | Times Cited: 37
Bruce Wang, Herbert L. Bonkovsky, Joseph K. Lim, et al.
Gastroenterology (2023) Vol. 164, Iss. 3, pp. 484-491
Open Access | Times Cited: 37
Update on heme biosynthesis, tissue‐specific regulation, heme transport, relation to iron metabolism and cellular energy
Audrey Belot, Hervé Puy, Iqbal Hamza, et al.
Liver International (2024) Vol. 44, Iss. 9, pp. 2235-2250
Open Access | Times Cited: 9
Audrey Belot, Hervé Puy, Iqbal Hamza, et al.
Liver International (2024) Vol. 44, Iss. 9, pp. 2235-2250
Open Access | Times Cited: 9
Advancing Therapeutic Strategies with Polymeric Drug Conjugates for Nucleic Acid Delivery and Treatment
Aftab Ullah, Marina Khan, Yibang Zhang, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 25-52
Open Access | Times Cited: 1
Aftab Ullah, Marina Khan, Yibang Zhang, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 25-52
Open Access | Times Cited: 1
Targeting the Liver with Nucleic Acid Therapeutics for the Treatment of Systemic Diseases of Liver Origin
Anagha Gogate, Jordyn Belcourt, Milan Shah, et al.
Pharmacological Reviews (2023) Vol. 76, Iss. 1, pp. 49-89
Open Access | Times Cited: 12
Anagha Gogate, Jordyn Belcourt, Milan Shah, et al.
Pharmacological Reviews (2023) Vol. 76, Iss. 1, pp. 49-89
Open Access | Times Cited: 12
The Fomivirsen, Patisiran, and Givosiran Odyssey: How the Success Stories May Pave the Way for Future Clinical Translation of Nucleic Acid Drugs
Mona Mansouri, Kimia Mansouri, Zahra Taheri, et al.
BioDrugs (2025)
Closed Access
Mona Mansouri, Kimia Mansouri, Zahra Taheri, et al.
BioDrugs (2025)
Closed Access
David Cassiman, Raili Kauppinen, Susana Monroy, et al.
Journal of Inherited Metabolic Disease (2022) Vol. 45, Iss. 6, pp. 1163-1174
Open Access | Times Cited: 16
Chitosan/siRNA nanoparticles targeting PARP-1 attenuate Neuroinflammation and apoptosis in hyperglycemia-induced oxidative stress in Neuro2a cells
Moqbel Ali Moqbel Redhwan, M. G. Hariprasad, Suman Samaddar, et al.
International Journal of Biological Macromolecules (2024) Vol. 282, pp. 136964-136964
Closed Access | Times Cited: 3
Moqbel Ali Moqbel Redhwan, M. G. Hariprasad, Suman Samaddar, et al.
International Journal of Biological Macromolecules (2024) Vol. 282, pp. 136964-136964
Closed Access | Times Cited: 3
RNA Combined with Nanoformulation to Advance Therapeutic Technologies
Eduarda Lima, Déborah dos Santos, Atena Liriel Souza, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1634-1634
Open Access | Times Cited: 7
Eduarda Lima, Déborah dos Santos, Atena Liriel Souza, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1634-1634
Open Access | Times Cited: 7
RNA therapeutics in targeting G protein-coupled receptors: Recent advances and challenges
Wanjun Yuan, Xiangyang Shi, Leo Tsz On Lee
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 2, pp. 102195-102195
Open Access | Times Cited: 2
Wanjun Yuan, Xiangyang Shi, Leo Tsz On Lee
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 2, pp. 102195-102195
Open Access | Times Cited: 2
Bioanalytical approaches to support the development of antibody-oligonucleotide conjugate (AOC) therapeutic proteins
Anthony Murphy, Ryan C. Hill, Michael J. Berna
Xenobiotica (2024) Vol. 54, Iss. 8, pp. 552-562
Closed Access | Times Cited: 1
Anthony Murphy, Ryan C. Hill, Michael J. Berna
Xenobiotica (2024) Vol. 54, Iss. 8, pp. 552-562
Closed Access | Times Cited: 1
Study on the molecular interactions between givosiran and theophylline by surface-enhanced Raman spectroscopy, biolayer interferometry, and visible/fluorescence spectroscopy
Lijuan He, Zhilan Lian, Jiadong Feng, et al.
Microchemical Journal (2024) Vol. 203, pp. 110846-110846
Closed Access | Times Cited: 1
Lijuan He, Zhilan Lian, Jiadong Feng, et al.
Microchemical Journal (2024) Vol. 203, pp. 110846-110846
Closed Access | Times Cited: 1
German Real-World Experience of Patients with Diverse Features of Acute Intermittent Porphyria Treated with Givosiran
Ilja Kubisch, Nils Wohmann, Thaddäus Till Wissniowski, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 22, pp. 6779-6779
Open Access | Times Cited: 1
Ilja Kubisch, Nils Wohmann, Thaddäus Till Wissniowski, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 22, pp. 6779-6779
Open Access | Times Cited: 1
Idiosyncratic drug-induced liver injury caused by givosiran in a patient with acute intermittent porphyria
D. Christopher, Denise Faust, Herbert L. Bonkovsky
Molecular Genetics and Metabolism Reports (2022) Vol. 34, pp. 100946-100946
Open Access | Times Cited: 7
D. Christopher, Denise Faust, Herbert L. Bonkovsky
Molecular Genetics and Metabolism Reports (2022) Vol. 34, pp. 100946-100946
Open Access | Times Cited: 7
Recurrent symptoms of acute intermittent porphyria after biochemical normalization with givosiran—An ongoing clinical conundrum
D. Christopher, Denise Faust, Herbert L. Bonkovsky
JIMD Reports (2022) Vol. 64, Iss. 2, pp. 146-149
Open Access | Times Cited: 6
D. Christopher, Denise Faust, Herbert L. Bonkovsky
JIMD Reports (2022) Vol. 64, Iss. 2, pp. 146-149
Open Access | Times Cited: 6
Long-term management and treatment of acute intermittent porphyria with recurring attacks using pharmacological prophylaxis
Hung‐Chou Kuo, Long‐Sun Ro, Chia‐Ni Lin, et al.
Hepatology Communications (2023) Vol. 7, Iss. 12
Open Access | Times Cited: 3
Hung‐Chou Kuo, Long‐Sun Ro, Chia‐Ni Lin, et al.
Hepatology Communications (2023) Vol. 7, Iss. 12
Open Access | Times Cited: 3
A Case of Hereditary Coproporphyria in which the Patient's Course Improved after the Discontinuation of Givosiran
Nobuaki Ozaki, Yuri Hayashi, Atsushi Kiyota
Internal Medicine (2024) Vol. 63, Iss. 21, pp. 2961-2964
Open Access
Nobuaki Ozaki, Yuri Hayashi, Atsushi Kiyota
Internal Medicine (2024) Vol. 63, Iss. 21, pp. 2961-2964
Open Access
Canadian guidance for diagnosis and management of acute hepatic porphyrias
Juan Idiáquez, Aditi Khandelwal, Bassam A Nassar, et al.
Clinical Biochemistry (2024) Vol. 131-132, pp. 110792-110792
Open Access
Juan Idiáquez, Aditi Khandelwal, Bassam A Nassar, et al.
Clinical Biochemistry (2024) Vol. 131-132, pp. 110792-110792
Open Access
Analysis of the binding specificity of N‐acetylgalactosamine (GalNAc )‐binding lectin isolated from Kappaphycus alvarezii to SARS ‐CoV ‐2 sugar moieties
Intan Mariana Maliki, Mailin Misson, Peik Lin Teoh, et al.
Phycological Research (2024)
Closed Access
Intan Mariana Maliki, Mailin Misson, Peik Lin Teoh, et al.
Phycological Research (2024)
Closed Access
Recent Insights into Nano-mediated siRNA Drug Delivery
Venkateshwaran Krishnaswami, Kumar Janakiraman, Vaidevi Sethuraman, et al.
Current Drug Metabolism (2024) Vol. 25, Iss. 8, pp. 554-563
Closed Access
Venkateshwaran Krishnaswami, Kumar Janakiraman, Vaidevi Sethuraman, et al.
Current Drug Metabolism (2024) Vol. 25, Iss. 8, pp. 554-563
Closed Access
Evaluating the Efficacy of a Small Interfering Ribonucleic Acid Molecule, Givosiran, in Treating Acute Intermittent Porphyria: A Systematic Review
Priyansh Patel, Sidharth Midha, Surmai Shukla, et al.
Cureus (2023)
Open Access | Times Cited: 1
Priyansh Patel, Sidharth Midha, Surmai Shukla, et al.
Cureus (2023)
Open Access | Times Cited: 1
Portuguese Consensus on Acute Porphyrias: Diagnosis, Treatment, Monitoring and Patient Referral
Luís Brito Avô, Luísa Pereira, Anabela Silveira de Oliveira, et al.
Acta Médica Portuguesa (2023) Vol. 36, Iss. 11, pp. 753-764
Open Access
Luís Brito Avô, Luísa Pereira, Anabela Silveira de Oliveira, et al.
Acta Médica Portuguesa (2023) Vol. 36, Iss. 11, pp. 753-764
Open Access
Acute Intermittent Porphyria: A Challenging Diagnosis and Treatment
Iago de Larrinaga Romero, Beatriz Elena Lence Massa, Emilio Rodríguez‐Ruiz
Lessons from the ICU (2023), pp. 539-546
Closed Access
Iago de Larrinaga Romero, Beatriz Elena Lence Massa, Emilio Rodríguez‐Ruiz
Lessons from the ICU (2023), pp. 539-546
Closed Access
Using RNAi in the treatment of cardiovascular diseases - therapeutics based on siRNA overview
Barbara Rusinowska
Journal of Education Health and Sport (2022) Vol. 12, Iss. 7, pp. 890-896
Open Access
Barbara Rusinowska
Journal of Education Health and Sport (2022) Vol. 12, Iss. 7, pp. 890-896
Open Access
